VERRICA PHARMACEUTICALS INC (VRCA) Institutional Shareholders
VERRICA PHARMACEUTICALS INC (VRCA) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $28.53M in VRCA holdings during the latest filing period.
Caligan Partners Lp is currently the largest disclosed institutional shareholder of VRCA tracked by InsiderSet, reporting ownership valued at approximately $5.65M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $4.11M, representing an estimated loss of -27.29% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 92% of the total disclosed VRCA value among the investors covered in this analysis. Major shareholders include Caligan Partners Lp, Cannell Capital Llc, Affinity Asset Advisors, Llc, and several other long-term asset managers with concentrated positions in VERRICA PHARMACEUTICALS INC (VRCA).
This page ranks the largest institutional VRCA shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
41
Total Reported Value
$28.53M
Largest Holder
Caligan Partners Lp
Largest Position
$5.65M
Insider Transactions (90d)
12
Latest Filing Quarter
Q2 2026
New Institutional Positions
60
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Caligan Partners Lp | 0.27% | 923,910 | $5,654,329 | $4,111,400 | -$1,542,930 | -27.29% | |
| Cannell Capital Llc | 3.35% | 783,923 | $4,797,609 | $3,488,457 | -$1,309,152 | -27.29% | |
| Affinity Asset Advisors, Llc | 0.21% | 707,338 | $4,328,909 | $3,147,654 | -$1,181,255 | -27.29% | |
| Velan Capital Investment Management Lp | 1.77% | 471,559 | $2,885,941 | $2,098,438 | -$787,503 | -27.29% | |
| Armistice Capital, Llc | 0.07% | 426,304 | $2,608,980 | $1,897,053 | -$711,927 | -27.29% | |
| Boothbay Fund Management, Llc | 0.03% | 280,734 | $1,718,092 | $1,249,266 | -$468,826 | -27.29% | |
| Vanguard Capital Management Llc | 0.00% | 279,310 | $1,709,377 | $1,242,930 | -$466,448 | -27.29% | |
| Mariner, Llc | 0.00% | 207,230 | $1,268,247 | $922,174 | -$346,074 | -27.29% | |
| Geode Capital Management, Llc | 0.00% | 138,160 | $845,656 | $614,812 | -$230,844 | -27.30% | |
| Blackrock, Inc. | 0.00% | 74,344 | $454,986 | $330,831 | -$124,155 | -27.29% | |
| Vanguard Fiduciary Trust Co | 0.00% | 70,173 | $429,459 | $312,270 | -$117,189 | -27.29% | |
| Two Sigma Investments, Lp | 0.00% | 40,825 | $249,849 | $181,671 | -$68,178 | -27.29% | |
| State Street Corp | 0.00% | 28,916 | $176,966 | $128,676 | -$48,290 | -27.29% | |
| Northern Trust Corp | 0.00% | 26,996 | $165,216 | $120,132 | -$45,084 | -27.29% | |
| Dafna Capital Management Llc | 0.03% | 23,750 | $145,350 | $105,688 | -$39,663 | -27.29% | |
| Jane Street Group, Llc | 0.00% | 23,654 | $144,762 | $105,260 | -$39,502 | -27.29% | |
| Verdad Advisers, Lp | 0.14% | 23,069 | $141,182 | $102,657 | -$38,525 | -27.29% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 21,769 | $133,226 | $96,872 | -$36,354 | -27.29% |
| Legacy Trust | 0.02% | 16,584 | $101,494 | $73,799 | -$27,695 | -27.29% | |
| Fifth Third Bancorp | 0.00% | 14,000 | $85,680 | $62,300 | -$23,380 | -27.29% | |
| Dimensional Fund Advisors Lp | 0.00% | 13,888 | $84,995 | $61,802 | -$23,193 | -27.29% | |
| Xtx Topco Ltd | 0.00% | 13,723 | $83,985 | $61,067 | -$22,918 | -27.29% | |
| Two Sigma Securities, Llc | 0.01% | 13,045 | $79,835 | $58,050 | -$21,785 | -27.29% | |
| Hrt Financial Lp | 0.00% | 13,023 | $79,000 | $57,952 | -$21,048 | -26.64% | |
| Beck Mack & Oliver Llc | 0.00% | 12,000 | $73,440 | $53,400 | -$20,040 | -27.29% | |
| Ubs Group Ag | 0.00% | 6,071 | $37,155 | $27,016 | -$10,139 | -27.29% | |
| Morgan Stanley | 0.00% | 3,201 | $19,590 | $14,244 | -$5,346 | -27.29% | |
| Capital Analysts, Llc | 0.00% | 1,500 | $9,000 | $6,675 | -$2,325 | -25.83% | |
| Vanguard Global Advisers, Llc | 0.00% | 862 | $5,275 | $3,836 | -$1,439 | -27.28% | |
| Royal Bank Of Canada | 0.00% | 764 | $5,000 | $3,400 | -$1,600 | -32.00% | |
| Tower Research Capital Llc (Trc) | 0.00% | 614 | $3,758 | $2,732 | -$1,026 | -27.29% | |
| Salomon & Ludwin, Llc | 0.00% | 290 | $1,723 | $1,291 | -$433 | -25.10% | |
| New England Capital Financial Advisors Llc | 0.00% | 200 | $1,224 | $890 | -$334 | -27.29% | |
| International Assets Investment Management, Llc | 0.00% | 175 | $1,040 | $779 | -$261 | -25.12% | |
| Bnp Paribas Financial Markets | 0.00% | 110 | $673 | $490 | -$184 | -27.27% | |
| Pnc Financial Services Group, Inc. | 0.00% | 92 | $563 | $409 | -$154 | -27.28% | |
| Barclays Plc | 0.00% | 64 | $392 | $285 | -$107 | -27.35% | |
| Jpmorgan Chase & Co | 0.00% | 47 | $306 | $209 | -$97 | -31.65% | |
| Ameritas Advisory Services, Llc | 0.00% | 30 | $184 | $134 | -$51 | -27.45% | |
| Jones Financial Companies Lllp | 0.00% | 26 | $178 | $116 | -$62 | -35.00% | |
| Valley National Advisers Inc | 0.00% | 25 | $153 | $111 | -$42 | -27.29% |
Frequently asked questions about VRCA
Who owns the most VRCA stock?
The largest holders of VRCA are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for VERRICA PHARMACEUTICALS INC (VRCA).
Is VRCA widely held by superinvestors?
Many widely followed stocks like VRCA appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly VRCA is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.